Candel Therapeutics, Inc. CADL Operating margin
Discontinued — last reported Q4 '22
Operating margin at other companies
Other financials
Where this comes from
Calculated from Candel Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Candel Therapeutics, Inc.’s 10-K, filed March 28, 2024, on SEC EDGAR. View the filing →
Ask your AI about Candel Therapeutics, Inc.'s operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Candel Therapeutics, Inc.'s operating margin?
- Candel Therapeutics, Inc. (CADL) reported operating margin of -28,000.8% in Q4 2022.
- How has Candel Therapeutics, Inc.'s operating margin changed year-over-year?
- Candel Therapeutics, Inc.'s operating margin decreased by 35.0% year-over-year, from -20,747.6% to -28,000.8%.
- What is the long-term trend for Candel Therapeutics, Inc.'s operating margin?
- Over 2 years (2020 to 2022), Candel Therapeutics, Inc.'s operating margin has grown at a 59.2% compound annual growth rate (CAGR), from -11,048% to -28,000.8%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.